Risperidone is not approved for treating anxiety disorders, and the clinical evidence for using it as a standalone anxiety treatment is mixed. In a controlled trial of patients with generalized anxiety disorder and panic disorder, risperidone was no more effective than a placebo over eight weeks. However, it does show real benefits for anxiety-like symptoms in specific situations, particularly when added to other medications for OCD or when used to treat PTSD-related nightmares.
Why Risperidone Is Sometimes Prescribed for Anxiety
Risperidone is an atypical antipsychotic. Its FDA-approved uses are schizophrenia, bipolar mania, and irritability linked to autism in children. Anxiety is not on that list, which means any prescription for anxiety is off-label.
Still, prescribers sometimes reach for it because of how it works in the brain. Risperidone strongly blocks serotonin receptors (specifically the 5-HT2A type) and also blocks dopamine receptors. That serotonin-blocking action is part of why it can calm certain anxiety-related symptoms. It also affects noradrenaline signaling, which plays a role in the “fight or flight” response and sleep disturbances. These overlapping effects on multiple brain chemicals are what make it theoretically useful for anxiety, even though the direct evidence is limited.
What the Evidence Says for Generalized Anxiety
The most rigorous test of risperidone as a dedicated anxiety treatment came from an eight-week, double-blind trial of 111 patients with bipolar disorder who also had generalized anxiety disorder or panic disorder. Patients took 0.5 to 4 mg per day. On every anxiety measure used, including clinician-rated anxiety scales, risperidone performed no better than placebo. This is a significant finding because it suggests risperidone alone is unlikely to meaningfully treat classic anxiety disorders like GAD or panic disorder.
A smaller comparative study did find that adding just 1 mg of risperidone to an SSRI antidepressant reduced anxiety levels within 10 days in patients with moderate to severe anxiety tied to depression, OCD, or GAD. The effect appeared before the SSRI would have fully kicked in (SSRIs typically take two to three weeks), suggesting risperidone contributed something on its own. But this was a small study, and the patients were taking an SSRI at the same time, so it’s hard to separate the effects cleanly.
Where Risperidone Does Help: OCD and PTSD
Treatment-Resistant OCD
The strongest anxiety-adjacent evidence for risperidone is in obsessive-compulsive disorder that hasn’t responded to standard treatment. In a study of 21 patients already taking an SSRI-type medication without adequate relief, adding risperidone (averaging about 2.75 mg per day) produced substantial symptom improvement in 87% of those who tolerated the combination. Those improvements appeared within three weeks. This makes risperidone one of the more commonly used add-on options when OCD doesn’t respond to an antidepressant alone.
PTSD-Related Nightmares
Risperidone also shows promise for the sleep-related symptoms of PTSD. Its ability to affect serotonin, dopamine, and noradrenaline signaling together allows it to influence brain areas involved in fear processing and sleep regulation. In a retrospective study of 65 combat veterans taking 0.5 to 4 mg per day, 43% reported complete nightmare cessation, and another 41.5% reported fewer and less intense nightmares. A separate trial found marked improvement in distressing dreams as early as six weeks. Even burn patients receiving an average of just 1 mg saw improvement in flashbacks and nightmares.
These results are encouraging, though most of these studies were small or retrospective rather than large-scale controlled trials.
Side Effects That Matter at Low Doses
Even at the low doses typically used for anxiety (0.5 to 2 mg per day), risperidone carries side effects that are worth understanding before starting it.
The most common ones are drowsiness, sedation, and fatigue. In clinical trials, these were among the top reasons people stopped taking the medication. Increased appetite and weight gain are also frequent. Studies have found meaningful increases in body mass index and blood sugar levels with risperidone use.
One side effect deserves special attention: akathisia, a feeling of inner restlessness that makes it hard to sit still. This is particularly relevant if you’re taking risperidone for anxiety, because akathisia can feel like worsening anxiety. In clinical trials, it affected 8 to 10% of adults at standard doses. At the lowest tested dose of 1 mg per day, movement-related side effects overall occurred in about 7% of patients. If you feel more restless or agitated after starting risperidone, that distinction between anxiety and akathisia is something to raise with your prescriber.
Risperidone also reliably raises prolactin, a hormone involved in breast milk production. Over 70% of women taking oral risperidone in studies showed prolactin levels above the normal range, and men are affected too. Elevated prolactin can cause missed periods, breast tenderness, and sexual side effects.
How It Compares to Standard Anxiety Medications
Benzodiazepines like clonazepam work within an hour by boosting a calming brain chemical called GABA. They are fast and reliably reduce acute anxiety, but they carry a well-known risk of tolerance, physical dependence, and withdrawal symptoms with long-term use.
Risperidone works through a completely different mechanism and does not carry the same addiction risk. In the comparative study that tested low-dose risperidone against clonazepam (both added to an SSRI), the 1 mg risperidone group saw significant anxiety reduction with minimal side effects: only two of 30 patients experienced mild side effects. The researchers suggested low-dose risperidone could be considered as an alternative to high-dose benzodiazepines in moderate to severe anxiety, particularly when dependence is a concern.
That said, risperidone brings its own set of risks that benzodiazepines don’t, including metabolic changes, prolactin elevation, and movement-related side effects. It’s not a straightforward swap. SSRIs and related antidepressants remain the first-line treatment for most anxiety disorders, with risperidone occupying a niche role for specific situations where standard treatments fall short.
The Bottom Line on Risperidone and Anxiety
Risperidone is not an effective standalone treatment for generalized anxiety or panic disorder based on the best available evidence. Where it shows real value is as an add-on medication: boosting SSRI treatment for stubborn OCD, reducing PTSD nightmares, or bridging the gap while a new antidepressant takes effect. If your prescriber has suggested risperidone for anxiety, it likely reflects one of these specific scenarios rather than a first-line approach to garden-variety anxiety.